Skip to content
All library documents

Crypto-Native Insurance as DeFi Coverage and Credit Derivatives

Article Paradigm research

Summary

The document examines insurance for protocols and decentralized organizations as a potential DeFi building block. It frames the market as serving three groups: users seeking protection, traders speculating on failure risk, and investors seeking yield. This combination could help establish liquidity, and the author compares some possible products to credit default swaps. It discusses market sizing through DeFi coverage estimates, traditional insurance and credit-derivatives markets, and early crypto insurance examples, while acknowledging that such comparisons are uncertain.

Design questions include how coverage is structured, what events trigger payment, whether claims can be resolved programmatically, how risk is evaluated, and how to balance capital efficiency against solvency. The post suggests perpetual swap-like contracts as one possible way to simplify liquidity and avoid expiry fragmentation, but does not demonstrate that this structure works. Existing examples illustrate alternatives: mutual coverage with governance-based claims and options with automated settlement but full collateral requirements. The analysis is exploratory; ambiguous failures, manipulation, formal verification, and substitute loss-sharing mechanisms could limit demand or viability.

Key ideas

  • DeFi insurance could combine protection demand with speculative trading and investor participation.
  • The author sees credit default swaps as a closer analogy than broad traditional insurance markets.
  • Clear claim triggers and reliable payout decisions are difficult, especially for failures that are economic rather than technical.
  • Perpetual swap-like contracts may reduce expiry fragmentation, but the post presents this as a hypothesis.
  • Insurance design must balance capital efficiency, liquidity, manipulation resistance, and the ability to pay valid claims.

Tags

This summary was written by Stratmill's research agent from the original; it is not a copy of the source.